BY ALBERT RONNING-ANDERSSON
-
Eli Lilly increases stake in biotech company: “An extremely strong signal”
When Biograil intends to increase as much as DKK 450 million in 2027, it is useful to have the ability to claim that the globe’s biggest pharmaceutical firm has greater than …
-
EU ready with long-awaited proposal for new medtech legislation: There is room for improvement
The present demand for necessary recertification every 5 years will certainly be eliminated, and a fast-track plan will certainly be presented. Nonetheless, crucial problems contin…
-
Industry passes judgment on new drug regulation: Better than feared, but a blow to Europe’s competitiveness
Novo Nordisk sees less financial investments in European life scientific researches as an outcome of brand-new EU contract. A lot more firms will certainly currently relocate tasks…
-
Former Novo executive joins new obesity and diabetes company: “A potential game changer”
The firm has actually elevated greater than DKK 100 million and is currently releasing a professional test in the United States with 400 individuals. If all goes as prepared, an it…
-
New huge investment in Danish biotech: Major investors inject USD 109m into two-year-old biotech prospect
Novo Holdings, Forbion, RA Resources Medical Care Fund, and Gilde Health care are the heavyweights in the distribute that has actually spent almost USD 109 million in Danish biotec…
-
Industry warns: EU agreement on critical medicines could create bureaucracy and hamper innovation
Danish Chamber of Business desires sector to be associated with the execution of the brand-new contract, and both Lif and the Chamber are increasing problems concerning administrat…
-
Industry warns: EU agreement on critical medicines could create bureaucracy and hamper innovation
Danish Chamber of Commerce wants industry to be involved in the implementation of the new agreement, and both Lif and the Chamber are raising concerns about bureaucracy and increas…
-
Industry warns: EU agreement on critical medicines could create bureaucracy and hamper innovation
Danish Chamber of Commerce wants industry to be involved in the implementation of the new agreement, and both Lif and the Chamber are raising concerns about bureaucracy and increas…
-
Outbound biotech CFO names new employer
” He has specifically the best experience and history,” states the firm’s chief executive officer, whom Morten Boesen will certainly change on December 1.
-
Biotech investor criticizes Bioport’s capital raising strategy
Bioport’s technique to elevating funding mishandles and has actually taken as well long, according to doubters.
